A viral SAVED protein with ring nuclease activity degrades the CRISPR second messenger cA4
Marta Orzechowski, Ville HoikkalaiD, Haotian ChiiD, Stephen McMahon, T.M. GlosteriD, Malcolm F. WhiteiD
Abstract
Type III CRISPR systems typically generate cyclic oligoadenylate (cOA) second messengers such as cyclic tetra-adenylate (cA4) on detection of foreign RNA, activating ancillary effector proteins which elicit a diverse range of immune responses. The CalpLTS system elicits a transcriptional response to infection when CalpL binds cA4 in its SAVED (SMODS associated and fused to various effectors domain) sensor domain, resulting in filament formation and activation of the Lon protease domain, which cleaves the anti-Sigma factor CalpT, releasing the CalpS Sigma factor for transcriptional remodelling. Here, we show that thermophilic viruses have appropriated the SAVED domain of CalpL as an anti-CRISPR, AcrIII-2, which they use to degrade cA4. AcrIII-2 dimers sandwich cA4, degrading it in a shared active site to short linear products, using a mechanism highly reminiscent of CalpL. This results in inhibition of a range of cA4 activated effectors in vitro. This is the first example of a virally-encoded SAVED domain with ring nuclease activity, highlighting the complex interplay between viruses and cellular defences.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.30
- Field percentile
- top 47%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease
Sophie C. Binder, Niels Schneberger, … Gregor Hagelueken·Nucleic Acids ResearchPeer-reviewed·Jul 24, 2024
- Filament formation activates protease and ring nuclease activities of CRISPR SAVED-Lon
Dalia Smalakytė, Audronė Rukšėnaitė, … Gintautas Tamulaitis·Molecular CellPeer-reviewed·Oct 2, 2024
- A viral ring nuclease anti-CRISPR subverts type III CRISPR immunity
J. S. Athukoralage, S. McMahon, … M. F. White·bioRxiv·Sep 24, 2019
- SAVED by a toxin: Structure and function of the CRISPR Lon protease.
C. Rouillon, N. Schneberger, … G. Hagelueken·bioRxiv·Dec 6, 2021
- The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling
J. S. Athukoralage, S. Grüschow, … M. F. White·bioRxiv·Feb 12, 2020
- A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator
J. S. Athukoralage, S. Graham, … M. F. White·bioRxiv·Mar 20, 2019